Patent · US Active

Microencapsulation process of sertoli cells, microcapsules obtained and use for treatment of type I diabetes mellitus

US8865218B2 · kind B2 · utility

0Cited by

3References

15Claims

0Family size

Assignee

GH CARE INC. · US

Inventors

Riccardo Calafiore · Perugia, IT
Giovanni Luca · Paola, IT
Mario Calvitti · Perugia, IT
Ennio Becchetti · Perugia, IT
Paolo Puccetti · Perugia, IT
Francesca Fallarino · Perugia, IT
Claudio Nastruzzi · Ferrara, IT

Key dates

Filing date	Dec 18, 2009
Grant date	Oct 21, 2014
Priority date	—
Expiry date	Jan 27, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of Sertoli cells (SC) microencapsulated into hydrogel-based microcapsules, for the prevention and/or treatment of Type 1 diabetes mellitus (T1DM) and to a process for producing microcapsules, preferably shaped as microspheres.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.